BRIEF-GSK exercises option over SPEAR T-cell therapy program targeting NY-ESO By: Reuters: Company News September 07, 2017 at 07:59 AM EDT * Adaptimmune Therapeutics Plc - GSK exercises option over SPEAR T-cell therapy program targeting NY-ESO Read More >> Related Stocks: Adaptimmune Ther ADR Gsk Plc ADR